CHICAGO, July 26, 2024 /PRNewswire/ — The Alzheimer’s Association is disappointed by today’s decision by the European Medicines Agency (EMA) to recommend against allowing Leqembi® to be marketed across the European Union. “The EMA has denied people living with Alzheimer’s and their…